Bibliography

Export 1797 results:
Filters: Keyword is Humans  [Clear All Filters]
1999
Villeneuve L, Cassaing S, Magnaval JF, Boisseau M, Huynh A, Demur C, et al. Plasmodium falciparum infection following allogeneic bone-marrow transplantation. AnnTropMedParasitol. 1999;93(5):533-535.
Rowley SD, Feng Z, Yadock D, Holmberg L, MacLeod B, Heimfeld S. Post-thaw removal of DMSO does not completely abrogate infusional toxicity or the need for pre-infusion histamine blockade. Cytotherapy. 1999;1(6):439-46.
Shapiro R, Nalesnik MA, McCauley J, Fedorek S, Jordan ML, Scantlebury VP, et al. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation. 1999;68(12):1851-4.
Penn I. Posttransplant malignancies. Transplant Proc. 1999;31(40575):1260-2.
Creange A, Duvoux C, Gray F, Dhumeaux D. [Prion diseases, the liver and the digestive system]. Gastroenterol Clin Biol. 1999;23(10):1013-8.
LeBlanc R, Roy J, Demers C, Vu L, Cantin G. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors. Bone Marrow Transplant. 1999;23(10):991-6.
Calvino J, Romero R, Pintos E, Novoa D, Mardaras J, Arcocha V, et al. Renal artery rupture secondary to pretransplantation Candida contamination of the graft in two different recipients. Am J Kidney Dis. 1999;33(1):E3.
Panda A, Pushker N, Nainiwal S, Satpathy G, Nayak N. Rhodotorula sp. infection in corneal interface following lamellar keratoplasty--a case report. Acta Ophthalmol Scand. 1999;77(2):227-8.
Przepiorka D, Smith TL, Folloder J, Khouri I, Ueno NT, Mehra R, et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood. 1999;94(4):1465-70.
Curtis RE, Travis LB, Rowlings PA, Socie G, Kingma DW, Banks PM, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood. 1999;94(7):2208-16.
Hogan RN, Brown P, Heck E, Cavanagh HD. Risk of prion disease transmission from ocular donor tissue transplantation. Cornea. 1999;18(1):2-11.
Chui AK, Herbertt K, Wang LS, Kyd G, Hodgeman G, Verran DJ, et al. Risk of tumor transmission in transplantation from donors with primary brain tumors: an Australian and New Zealand registry report. Transplant Proc. 1999;31(40575):1266-7.
Rowley S, MacLeod B, Heimfeld S, Holmberg L, Bensinger W. Severe central nervous system toxicity associated with the infusion of cryopreserved PBSC components. Cytotherapy. 1999;1(4):311-7.
Cash KL, Brown T, Sausais L, Uehlinger J, Reed LJ. Severe delayed hemolytic transfusion reaction secondary to anti-At(a). Transfusion. 1999;39(8):834-7.
Mitchell S, James A. Severe hemolytic disease from rhesus anti-C antibodies in a surrogate pregnancy after oocyte donation. A case report. J Reprod Med. 1999;44(4):388-90.
Clarke GN. Sperm cryopreservation: is there a significant risk of cross-contamination? Hum Reprod. 1999;14(12):2941-3.
Falzetti F, Aversa F, Minelli O, Tabilio A. Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor. Lancet. 1999;353(9152):555.
Hwang YJ, Chang BH, Kim JW, Choi GS, Yun YK, Chui A, et al. Successful resection of cecal hepatic metastasis extending into the right side of the heart under cardiopulmonary bypass. J Hepatobiliary Pancreat Surg. 1999;6(3):320-3.
CDC. Transfusion-transmitted malaria--Missouri and Pennsylvania, 1996-1998. MMWR. Morbidity and mortality weekly report//MMWR Morb Mortal Wkly Rep. 1999;48(12):253-6.
Catlin EA, D., Roberts J. J, Erana R, Preffer FI, Ferry JA, Kelliher AS, et al. Transplacental transmission of natural-killer-cell lymphoma. N Engl J Med. 1999;341(2):85-91.
Sanders SA, Reinisch JM. Would you say you "had sex" if...? JAMA. 1999;281(3):275-7.

Pages